ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Long-term therapy: obstacles to be addressed
Mon 29 Aug 08:30 - 10:00 Drug therapy Abstract Session Brussels - Zone D
Chairpersons: Juan Luis TAMARGO (Madrid, ES), Keld Per KJELDSEN (Copenhagen, DK)

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
08:301907Long-term follow-up of the patients with Aspirin resistant end stage kidney disease Cuneyt KOCAS (Istanbul, TR)
08:451908Good short-term but not long-term reproducibility of the antiplatelet efficacy laboratory assessmentJan VOJACEK (Prague 4, CZ)
09:001909Prevention of peptic ulcers with once-daily esomeprazole 20 mg and 40 mg in low-dose acetylsalicylic acid users at gastrointestinal risk: outcome analysis by cardiovascular risk (OBERON)James SCHEIMAN (Ann Arbor, US)
09:151910Benefits and safety of long-term fenofibrate therapy in people with type 2 diabetes mellitus and renal impairment - the FIELD studyRu-Dee TING (Balmain, AU)
09:301911Long-term effects of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease and the metabolic syndromeHideki WATANABE (Joso, JP)
09:451912Effective management of glycosylated hemoglobin levels with niacin extended release among patients with type II diabetes mellitusRobert SIMKO (Chicago, US)